News
Baxter (NYSE:BAX) is facing potential issues with its infusion pumps that has resulted in patient deaths, the FDA says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback